{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T05:44:59Z","timestamp":1794203099092,"version":"4.8.0"},"reference-count":30,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Erythema multiforme (EM) is an immune-mediated condition that classically presents with discrete targetoid lesions and can involve both mucosal and cutaneous sites. While EM is typically preceded by viral infections, most notably herpes simplex virus (HSV), and certain medications, a large portion of cases are due to an unidentifiable cause. EM can be confused with other more serious conditions like Stevens\u2013Johnson syndrome (SJS); however, clinical research has provided significant evidence to classify EM and SJS as separate disorders. Treatment of EM is highly variable, depending on the etiology, the involvement of mucosal sites, and the chronicity (acute vs. recurring) of the disease. If the etiology or causal medication\/infection is identified, then the medication is stopped and\/or the infection is treated prior to initiating symptomatic treatment. Treatment for acute EM is focused on relieving symptoms with topical steroids or antihistamines. Treatment for recurrent EM is most successful when tailored to individual patients. First line treatment for recurrent EM includes both systemic and topical therapies. Systemic therapies include corticosteroid therapy and antiviral prophylaxis. Topical therapies include high-potency corticosteroids, and antiseptic or anesthetic solutions for mucosal involvement. Second-line therapies for patients who do not respond to antiviral medications include immunosuppressive agents, antibiotics, anthelmintics, and antimalarials<\/jats:p>","DOI":"10.3390\/medicina57090921","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T11:39:03Z","timestamp":1630496343000},"page":"921","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Recent Updates in the Treatment of Erythema Multiforme"],"prefix":"10.3390","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0170-6262","authenticated-orcid":false,"given":"Alexa","family":"Soares","sequence":"first","affiliation":[{"name":"Mayo Clinic Alix School of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olayemi","family":"Sokumbi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL 32224, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1365-4632.2011.05348.x","article-title":"Clinical Features, Diagnosis, and Treatment of Erythema Multiforme: A Review for the Practicing Dermatologist","volume":"51","author":"Sokumbi","year":"2012","journal-title":"Int. J. Dermatol."},{"key":"ref_2","first-page":"82","article-title":"Erythema Multiforme: Recognition and Management","volume":"100","author":"Trayes","year":"2019","journal-title":"Am. Fam. Phys."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaad.2009.06.046","article-title":"Recurrent Erythema Multiforme: Clinical Characteristics, Etiologic Associations, and Treatment in a Series of 48 Patients at Mayo Clinic, 2000 to 2007","volume":"62","author":"Wetter","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0190-9622(83)80003-6","article-title":"Erythema Multiforme: A Critical Review of Characteristics, Diagnostic Criteria, and Causes","volume":"8","author":"Huff","year":"1983","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0190-9622(84)80090-0","article-title":"Erythema Multiforme: Clinical, Histopathologic, and Immunologic Study","volume":"10","author":"Howland","year":"1984","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_6","first-page":"e3459","article-title":"Variants of Erythema Multiforme: A Case Report and Literature Review","volume":"10","author":"Paulino","year":"2018","journal-title":"Cureus"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/archderm.1996.03890300141023","article-title":"Erythema Multiforme with Mucous Membrane Involvement and Stevens-Johnson Syndrome Are Clinically Different Disorders","volume":"132","author":"Bystryn","year":"1996","journal-title":"Arch. Dermatol."},{"key":"ref_8","first-page":"40","article-title":"Rowell Syndrome: A Diagnostic Challenge","volume":"13","author":"Gallo","year":"2020","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Gargiulo, L., Pavia, G., Facheris, P., Valenti, M., Sacrini, F., Narcisi, A., Borroni, R., Costanzo, A., and Mancini, L.L. (2020). A Fatal Case of COVID-19 Infection Presenting with an Erythema Multiforme-like Eruption and Fever. Dermatologic Therapy, John Wiley & Sons.","DOI":"10.1111\/dth.13779"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Jimenez-Cauhe, J., Ortega-Quijano, D., Carretero-Barrio, I., Suarez-Valle, A., Saceda-Corralo, D., Del Real, C.M.G., and Fernandez-Nieto, D. (2020). Erythema Multiforme-like Eruption in Patients with COVID-19 Infection: Clinical and Histological Findings. Clinical and Experimental Dermatology, Wiley-Blackwell Publishing.","DOI":"10.1111\/ced.14281"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/sj.bdj.4806846","article-title":"Recurrent Erythema Multiforme: A Possible Role of Foodstuffs","volume":"166","author":"Lewis","year":"1989","journal-title":"Br. Dent. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2133.1993.tb00232.x","article-title":"Recurrent Erythema Multiforme: Clinical Features and Treatment in a Large Series of Patients","volume":"128","author":"Schofield","year":"1993","journal-title":"Br. J. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1600-0560.1994.tb00281.x","article-title":"Examination of Non-involved Skin, Previously Involved Skin, and Peripheral Blood for Herpes Simplex Virus DNA in Patients with Recurrent Herpes-associated Erythema Multiforme","volume":"21","author":"Brice","year":"1994","journal-title":"J. Cutan. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000074112","article-title":"Detection of Herpes Simplex Virus Genomic DNA in Various Subsets of Erythema Multiforme by Polymerase Chain Reaction","volume":"207","author":"Ng","year":"2003","journal-title":"Dermatology"},{"key":"ref_15","first-page":"333","article-title":"Persistent Erythema Multiforme and CMV Infection","volume":"6","author":"Wanner","year":"2007","journal-title":"J. Drugs Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0190-9622(95)91435-8","article-title":"Persistent Erythema Multiforme: Report of Two New Cases and Review of Literature","volume":"33","author":"Drago","year":"1995","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/jdv.15447","article-title":"Interventions for Erythema Multiforme: A Systematic Review","volume":"33","author":"Sbidian","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2133.1995.tb05024.x","article-title":"A Double-blind, Placebo-controlled Trial of Continuous Acyclovir Therapy in Recurrent Erythema Multiforme","volume":"132","author":"Tatnall","year":"1995","journal-title":"Br. J. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Demirba\u015f, A., Elmas, \u00d6.F., Atasoy, M., T\u00fcrsen, \u00dc., and Lotti, T. (2020). A Case of Erythema Multiforme Major in a Patient with COVID 19: The Role of Corticosteroid Treatment. Dermatologic Therapy, John Wiley & Sons.","DOI":"10.1111\/dth.13899"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/ICO.0b013e31802eb264","article-title":"Erythema Multiforme, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis: Acute Ocular Manifestations, Causes, and Management","volume":"26","author":"Chang","year":"2007","journal-title":"Cornea"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1016\/j.oooo.2019.11.013","article-title":"Recurrent Oral Erythema Multiforme: A Case Series Report and Review of the Literature","volume":"129","author":"Du","year":"2020","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e12449","DOI":"10.1111\/dth.12449","article-title":"Treatment of Antiviral-Resistant Recurrent Erythema Multiforme with Dapsone","volume":"30","author":"Oak","year":"2017","journal-title":"Dermatol. Ther."},{"key":"ref_23","first-page":"375","article-title":"Traitement Par Thalidomide, de l\u2019erytheme Polymorphe Chronique Formes Recidivantes et Subintrantes. Etude Retrospective de 26 Malades","volume":"123","author":"Cherouati","year":"1996","journal-title":"Ann. Dermatol. Venereol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/00128071-200809020-00006","article-title":"Persistent Erythema Multiforme Treated with Thalidomide","volume":"9","author":"Chen","year":"2008","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jdermsci.2018.08.002","article-title":"The Effect of Levamisole in the Treatment of Recalcitrant Recurrent Erythema Multiforme Major: An Observational Study","volume":"92","author":"Liu","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jdcr.2016.11.009","article-title":"Treatment of Recurrent Erythema Multiforme with Adalimumab as Monotherapy","volume":"3","author":"Baillis","year":"2017","journal-title":"JAAD Case Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1002\/art.21306","article-title":"Adalimumab for the Treatment of Patients with Moderately to Severely Active Psoriatic Arthritis: Results of a Double-Blind, Randomized, Placebo-Controlled Trial","volume":"52","author":"Jmease","year":"2005","journal-title":"Arthritis Rheum."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1046\/j.1523-1747.1999.00754.x","article-title":"Herpes Simplex Virus Associated Erythema Multiforme (HAEM) Is Mechanistically Distinct from Drug-Induced Erythema Multiforme: Interferon-\u03b3 Is Expressed in HAEM Lesions and Tumor Necrosis Factor-\u03b1 in Drug-Induced Erythema Multiforme Lesions","volume":"113","author":"Kokuba","year":"1999","journal-title":"J. Investig. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/jdv.13313","article-title":"Rituximab, a New Treatment for Difficult-to-Treat Chronic Erythema Multiforme Major? Five Cases","volume":"30","author":"Hirsch","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5070\/D3231033682","article-title":"Apremilast for Treatment of Recurrent Erythema Multiforme","volume":"23","author":"Chen","year":"2017","journal-title":"Dermatol. Online J."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/9\/921\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:54:06Z","timestamp":1760165646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/9\/921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["medicina57090921"],"URL":"https:\/\/doi.org\/10.3390\/medicina57090921","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]}}}